Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression

INTRODUCTION: Ketamine treatment is capable of significant and rapid symptom improvement in adults with treatment-resistant depression (TRD). A limitation of ketamine treatment in TRD is the relatively short duration of time to relapse (e.g., median 2–4 weeks). The objective of the systematic review...

Descripción completa

Detalles Bibliográficos
Autores principales: McMullen, Eric P., Lee, Yena, Lipsitz, Orly, Lui, Leanna M. W., Vinberg, Maj, Ho, Roger, Rodrigues, Nelson B., Rosenblat, Joshua D., Cao, Bing, Gill, Hartej, Teopiz, Kayla M., Cha, Danielle S., McIntyre, Roger S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189962/
https://www.ncbi.nlm.nih.gov/pubmed/33929660
http://dx.doi.org/10.1007/s12325-021-01732-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189962/
https://www.ncbi.nlm.nih.gov/pubmed/33929660
http://dx.doi.org/10.1007/s12325-021-01732-8

Ejemplares similares